$SIEN News

Last published 2y ago

2y agoSIENSientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionGlobeNewswireTiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra's breast reconstruction and augmentation business Nuance Intermediary, LLC is the successful bidder for substantially all of
2y agoSIENSientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessGlobeNewswireIRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a surgical aesthetics company developing and commercializing safe and innovative solutions for the best
2y agoSIENAutologous Fat Grafting to the Face With Use of the Viality™ System - NCT06169670ClinicalTrials.govFacial Fat Volume Retention
3y agoSIENSientra, Inc. (SIEN) Q3 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoSIENSientra Reports Third Quarter Financial and Operational ResultsGlobeNewswireIRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic
3y agoSIENSientra to Present at the Stifel 2023 Healthcare ConferenceGlobeNewswireIRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic
3y agoSIENSientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on OutlookGlobeNewswireIRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today
3y agoSIENSientra Reports Record Second Quarter Financial and Operational ResultsGlobeNewswireRevenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement inoperating cash flow and adjusted
3y agoSIENSientra to Report Second Quarter 2023 Financial Results on August 10, 2023GlobeNewswireIRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN)("Sientra" or the "Company"), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic
3y agoAZYO BIOL BTCY ETON+2SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdatePR NewswireDALLAS, July 17, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage
3y agoSIENSientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireIRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on June 27, 2023, the
3y agoSIENSientra Announces Appointment of Alexander W. Casdin to Board of DirectorsGlobeNewswireIRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced the
3y agoSIENSientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue ExpanderGlobeNewswireSignificant Milestone as the First, and Only, MRI-Compatible Tissue Expander Available on the US Market Continues Sientra's Leadership and Innovation in Breast Reconstruction IRVINE, Calif., June 08, 2023 (GLOBE
3y agoSIENSientra Announces FDA-Clearance of Novel Portfinder™ TechnologyGlobeNewswireIRVINE, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced that
3y agoSIENSientra Reports Record First Quarter 2023 Operational ResultsGlobeNewswireIRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Eleventh consecutive quarter of year-over-year growth, fueled by market outperformance in reconstruction Continued improvement in non-GAAP OPEX, adjusted EBITDA, and
3y agoCUTR ESTA FAZE MDT+5Cutera Announces Agreements with Pura Vida and RTWBusiness WireKevin Cameron, Taylor Harris, Nick Lewin and Keith Sullivan to Join the Cutera Board Following the June 9 Special Meeting Pura Vida and RTW to Vote Against Removal of Directors at the Special Meeting and Support the
3y agoSIENSientra to Report First Quarter 2023 Financial Results on May 11, 2023GlobeNewswireIRVINE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today
3y agoSIENSientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product LaunchesGlobeNewswireContinued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free cash flow results
3y agoAZYO SIENAziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women's Access to Biologics for Soft Tissue ReconstructionGlobeNewswireSILVER SPRING, Md. and IRVINE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (NASDAQ:AZYO) ("Aziyo"), a company that develops and commercializes biologic products to improve compatibility between
3y agoSIENSientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023GlobeNewswireIRVINE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today
3y agoSIENSientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality™ Fat Transfer SystemGlobeNewswireIRVINE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it has begun
3y agoSIENSientra Announces 1-for-10 Reverse Stock SplitGlobeNewswireIRVINE, Calif., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that its Board of Directors
3y agoSIENSientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireSANTA BARBARA, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on December 27,
3y agoSIENSientra Expands Global Footprint With Regulatory Approval to Market Breast Implants in the United Arab EmiratesGlobeNewswireIRVINE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced
4y agoSIENSientra Reports Record Third Quarter 2022 Financial ResultsGlobeNewswireSANTA BARBARA, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today
4y agoSIENSientra to Report Third Quarter 2022 Financial Results on November 10, 2022GlobeNewswireSANTA BARBARA, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today
4y agoSIENSientra Announces Pricing of $13.2 Million Public OfferingGlobeNewswireSANTA BARBARA, Calif., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today
4y agoSIENSientra Announces Proposed Public OfferingGlobeNewswireSANTA BARBARA, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today
4y agoSIENSientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield ManagementGlobeNewswireAnticipates total third quarter net sales of $21.5-$22.5 million, up 10-15% compared to the prior year period Restructured balance sheet with senior secured convertible debt with Deerfield Management SANTA BARBARA,
4y agoSIENSientra Supports Breast Cancer Awareness Month by Launching Educational Programs Designed to Empower WomenGlobeNewswireSANTA BARBARA, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced the launch of several initiatives in honor of Breast Cancer Awarene
4y agoSIENSientra Receives Regulatory Approval to Market Breast Implants in Saudi ArabiaGlobeNewswireSANTA BARBARA, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that it has received ap
4y agoSIENSientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireSANTA BARBARA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on August 29, 2022, the Company approved equit
4y agoSIENSientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction ChannelGlobeNewswireSANTA BARBARA, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results fo
4y agoSIENSientra to Report Second Quarter 2022 Financial Results on August 11, 2022GlobeNewswireSANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release fi
4y agoSIENSientra Wins Premier's Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value CreationGlobeNewswireSANTA BARBARA, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a leading medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, was recently honored with the 20
4y agoSIENFDA Approves Sientra's Low Plus Profile Projection Breast ImplantGlobeNewswireSANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company") announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augme
4y agoSIENSientra To Present At The William Blair 42nd Annual Growth Stock ConferenceGlobeNewswireSANTA BARBARA, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), announced today its participation at the William Blair 42nd Annual Growth Stock Conference, which takes place June 6-9, 2022. As part of t
4y agoSIENSientra To Participate At The 19th Annual Craig-Hallum Institutional Investor ConferenceGlobeNewswireSANTA BARBARA, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), announced today its participation at the Virtual 19th Annual Craig-Hallum Institutional Investor Conference, which takes place June 1st, 2
4y agoSIENSientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022GlobeNewswireRecord Growth Driven by Continued Expansion of Augmentation and Reconstruction Accounts Accelerated Gross Margin Improvement Through Execution of Commercial and Operational Plans SANTA BARBARA, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Sientra, In
4y agoSIENSientra to Report First Quarter 2022 Financial Results on May 12, 2022GlobeNewswireSANTA BARBARA, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release fin
4y agoSIENSientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDTGlobeNewswireSANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that Company CEO Ron Me
4y agoSIENSientra Receives Regulatory Approval to Market Breast Implants in CanadaGlobeNewswireSANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that it has received ap
4y agoSIENSientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021GlobeNewswireSixth Consecutive Quarter of Record Growth Doubled Augmentation and Reconstruction Market Share Since 2019 Broadened Market Opportunity with Addition of Novel, FDA-Cleared Fat Grafting Technology SANTA BARBARA, Calif., M
4y agoSIENSientra to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022GlobeNewswireSANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release fi
4y agoSIENSientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 RevenuesGlobeNewswireEstimates highest ever Breast Products yearly revenue of $80-$81 million representing 46%-47% full year growth Results driven by continued strong demand for Sientra Breast Products and commercial execution SANTA BARBARA, Calif., Jan. 10, 2022
4y agoSIENSientra Announces Acquisition of Novel Fat Grafting Technology from AuraGen Aesthetics, LLCGlobeNewswireBroadens Sientra's opportunity within the estimated $13 billion U.S. plastic surgery market1 with the addition of a highly differentiated, FDA-cleared fat grafting technology Leverages Sientra's existing commercial team and strong brand reputation
4y agoSIENSientra to Present at the H.C. Wainwright Bioconnect Virtual ConferenceGlobeNewswireSANTA BARBARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that members of manageme
4y agoSIENSientra Selects Leading Distributors for Two Key International Markets In Preparation for Further Expansion and Growth AccelerationGlobeNewswireSANTA BARBARA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it has entered into
5y agoSIENSientra Reports Record Third Quarter 2021 Revenue for Continuing OperationsGlobeNewswireSANTA BARBARA, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results fo
5y agoSIENSientra to Participate in Upcoming Investor ConferencesGlobeNewswireSANTA BARBARA, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that members of management are scheduled to participat